Evidence map›Paper›PMID 28437540›Full record

ArticleJAMA neurology2017

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Weihua Zhao, David R Beers, Kristopher G Hooten, Douglas H Sieglaff, Aijun Zhang, Shanker Kalyana-Sundaram, Christopher M Traini, Wendy S Halsey, Ashley M Hughes, Ganesh M Sathe and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 169 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. ERVK activity in CD8Journal of neuroinflammation · 2026
    Article
  6. Article
  7. Macrophages in Hematopoiesis and Related Blood Diseases.Genomics, proteomics & bioinformatics · 2025
    Review
  8. Article
  9. Integrative genomics and functional immunology reveal Clostridia species as modulators of neuroinflammation in amyotrophic lateral sclerosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  19. Review
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Weihua ZhaoDepartment of Neurology, Peggy and Gary Edwards ALS Laboratory, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston, Texas.
David R BeersDepartment of Neurology, Peggy and Gary Edwards ALS Laboratory, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston, Texas.
Kristopher G HootenDepartment of Neurosurgery, University of Florida, Gainesville.
Douglas H SieglaffTexas Genomic Medicine Research Program, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston, Texas.
Aijun ZhangDepartment of Medicine, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston, Texas.
Shanker Kalyana-SundaramTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Christopher M TrainiTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Wendy S HalseyTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Ashley M HughesTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Ganesh M SatheTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
George P LiviTarget Sciences at GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Guo-Huang FanGlaxoSmithKline R&D, Shanghai, China.
Stanley H AppelDepartment of Neurology, Peggy and Gary Edwards ALS Laboratory, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston, Texas.
Houston Methodist · USGlaxoSmithKline (United States) · USTarget (United States) · USGlaxoSmithKline (China) · CNUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Amyotrophic lateral sclerosis (ALS) is a common adult-onset neurodegenerative disease characterized by selective loss of upper and lower motor neurons. Patients with ALS have persistent peripheral and central inflammatory responses including abnormally functioning T cells and activated microglia. However, much less is known about the inflammatory gene profile of circulating innate immune monocytes in these patients. Objective: To characterize the transcriptomics of peripheral monocytes in patients with ALS. Design, Setting, and Participants: Monocytes were isolated from peripheral blood of 43 patients with ALS and 22 healthy control individuals. Total RNA was extracted from the monocytes and subjected to deep RNA sequencing, and these results were validated by quantitative reverse transcription polymerase chain reaction. Main Outcomes and Measures: The differential expressed gene signatures of these monocytes were identified using unbiased RNA sequencing strategy for gene expression profiling. Results: The demographics between the patients with ALS (mean [SD] age, 58.8 [1.57] years; 55.8% were men and 44.2% were women; 90.7% were white, 4.65% were Hispanic, 2.33% were black, and 2.33% were Asian) and control individuals were similar (mean [SD] age, 57.6 [2.15] years; 50.0% were men and 50.0% were women; 90.9% were white, none were Hispanic, none were black, and 9.09% were Asian). RNA sequencing data from negative selected monocytes revealed 233 differential expressed genes in ALS monocytes compared with healthy control monocytes. Notably, ALS monocytes demonstrated a unique inflammation-related gene expression profile, the most prominent of which, including IL1B, IL8, FOSB, CXCL1, and CXCL2, were confirmed by quantitative reverse transcription polymerase chain reaction (IL8, mean [SE], 1.00 [0.18]; P = .002; FOSB, 1.00 [0.21]; P = .009; CXCL1, 1.00 [0.14]; P = .002; and CXCL2, 1.00 [0.11]; P = .01). Amyotrophic lateral sclerosis monocytes from rapidly progressing patients had more proinflammatory DEGs than monocytes from slowly progressing patients. Conclusions and Relevance: Our data indicate that ALS monocytes are skewed toward a proinflammatory state in the peripheral circulation and may play a role in ALS disease progression, especially in rapidly progressing patients. This increased inflammatory response of peripheral immune cells may provide a potential target for disease-modifying therapy in patients with ALS.

Indexed as

Disease ProgressionGene Expression ProfilingAmyotrophic Lateral SclerosisFemaleHumansInflammationMaleMiddle AgedMonocytesPhenotypeSequence Analysis, RNA

Identifiers

PMID28437540
PMCPMC5822209
OpenAlexW2607829140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.